All In Biotech

Drug Trial Radar · NCT03247517

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD

Evaluation of SPN 812 (Viloxazine Extended-release Capsule) 200 and 400 mg Efficacy and Safety in Adolescents With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial

Last checked: Nov 20, 2026Latest source record: Jun 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Title says "pivotal". Randomized with 310 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

310

Actual

Start

Nov 2, 2017

Primary completion

Oct 17, 2018

Study completion Oct 17, 2018

Sponsor

Lead sponsor
Supernus Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Aug 11, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy and safety of low doses of SPN-812 in adolescents 12-17 years of age.

Conditions

  • ADHD

Interventions

  • PlaceboDrug

    Placebo was administered once daily

  • 200mg SPN-812Drug

    200mg SPN-812 was administered once daily and compared to placebo

  • 400mg SPN-812Drug

    400mg SPN-812 was administered once daily and compared to placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of SPN-812 Assessed by Attention-Deficit/Hyperactivity Disorder Rating Scale, 5th Edition (ADHD-RS-5)Time frame: Baseline and Week 6 (End of Study)

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Harmonex Neuroscience Research

    Dothan, Alabama

  • Neuropsychiatric Research Center of Orange County

    Orange, California

  • Indago Research & Health Center, Inc.

    Hialeah, Florida

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida

  • Miami Clinical Research

    Miami, Florida

  • Advanced Clinical Research

    Meridian, Idaho

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • Finger Lakes Clinical Research

    Rochester, New York

  • Clinical Neuroscience Solutions, Inc.

    Memphis, Tennessee

  • Texas Physicians Medical Research Group

    Arlington, Texas

  • Houston Clinical Trials

    Houston, Texas

  • Family Psychiatry of the Woodlands

    The Woodlands, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.